Filariasis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 45: Line 45:


The recommended treatment for patients outside the United States is [[albendazole]] (a broad spectrum [[anthelmintic]]) combined with [[ivermectin]].<ref name="CDC">{{Citation|author=U.S. Centers for Disease Control|title= Lymphatic Filariasis Treatment|url=http://www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/treatment_lymphatic_filar.htm|accessdate=2008-07-17}}</ref> A combination of [[diethylcarbamazine]] (DEC) and albendazole is also effective. All of these treatments are microfilaricides; they have no effect on the adult worms.
The recommended treatment for patients outside the United States is [[albendazole]] (a broad spectrum [[anthelmintic]]) combined with [[ivermectin]].<ref name="CDC">{{Citation|author=U.S. Centers for Disease Control|title= Lymphatic Filariasis Treatment|url=http://www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/treatment_lymphatic_filar.htm|accessdate=2008-07-17}}</ref> A combination of [[diethylcarbamazine]] (DEC) and albendazole is also effective. All of these treatments are microfilaricides; they have no effect on the adult worms.
===Primary prevention===
There are many primary preventive measures available for filariasis. Wearing appropriate clothing, Avoid outbreaks, Insecticides and Spatial Repellents,Bed nets and Mass drug treatment programs are efficient ways to prevent filariasis.


==References==
==References==

Revision as of 16:10, 29 June 2017

Filariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Filariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Filariasis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Filariasis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Filariasis overview

on Filariasis overview

Filariasis overview in the news

Blogs on Filariasis overview

Directions to Hospitals Treating Filariasis

Risk calculators and risk factors for Filariasis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lymphatic Filariasis (Philariasis) is a parasitic and infectious tropical disease, caused by three thread-like parasitic filarial worms called nematode worms, Wuchereria bancrofti, Brugia malayi, and Brugia timori, all transmitted by mosquitoes. It is extremely rare in Western countries. Loa loa is another filarial parasite of humans, transmitted by the deer fly.

Historical Perspective

Filariasis is believed to be found since the 16th century as Jan Huygen Linschoten put an overall idea about the disease when he went to Goa. Moving forward through the 19th century there was many discoveries regarding filariasis and the infective worms and the arthropod vectors. In 1866, the detection of the microfilariae in urine and blood. 10 years later in 1876, Joseph Bancroft discovered the adult worm which is responsible for the infection and named after that as Wuchereria Bancrofti. Through the next years till 1900s more discoveries and description of the life cycles of the worms had been known.[1]

Classification

Filariasis disease can be classified based on the site of infection. It is caused by different types of roundworms that infect particular site in the body. A group of these worms infect the lymphatic vessels causing lymphatic filariasis. Others infect serous cavities and subcutaneous tissues. It can be also classified into acute and chronic filariasis.

Pathophysiology

Filariasis infection occurs when a larva carrying mosquito bites individual skin introducing these larvae onto the skin. The larvae then enter the patient blood through the skin wound and spread to the different sites of infection either lymphatic vessels, subcutaneous tissues or the serous cavities. At those different sites, The larvae tend to mature in a six to twelve months process to be adult filariae which can live up to fifteen years. Reproduction takes place between the male and female adult worms producing microfilariae which are premature organisms with sheath that circulate the blood in case they are settled in the lymphatic vessels. During another blood meal, the mosquito takes up the microfilariae then those microfilariae lose their sheath within two weeks to be larvae that enter the human body when the human is bitten by a mosquito and the cycle restarts again. Pathogenesis of the disease depends on number of factors including immune response of the patient, the number of secondary bacterial infections, the accumulation of the worm antigens, release of Wolbachia bacteria from the worm and the genetic predisposition.[1]

Causes

Filariasis is caused by the parasitic organisms nematodes which are round worms or thread worms that infects mainly lymphatic vessels causing lympphatic filariasis. The three main nematodes that cause lymphatic filariasis are Wuchereria bancrofti, Brugia malayi and Brugia timori. Other nematodes include Loa loa (the eye worm), Mansonella streptocerca, and Onchocerca volvulus that cause subcutaneous filariasis. Mansonella perstans and Mansonella ozzardi cause serous cavity filariasis.[2][1]

Epidemiology and Demographics

Filariasis is endemic in tropical regions of Asia, Africa, Central and South America with 120 million people infected. In endemic areas of the world (e.g., Malaipea in Indonesia), up to 54% of the population may have microfilariae in their blood.[3]

Risk factors

Common risk factors in the development of filariasis are exposure to mosquitoes for long time and getting bitten by them many times and people living in tropical areas for long time.

Screening

Screening has been important to be performed especially among the people of Asian countries like Malaysia, China and India. It is important among people who work in agriculture field which may be home for the infected mosquitoes and vectors so, these people are more vulnerable to get infected. Two known tests for the screening which are dipstick colloidal dye immunoassay and ICT filariasis test kit.

Natural history, complications and prognosis

If left untreated, patients with lymphatic filariasis may progress to develop chronic lymphedema, hydrocele, skin pigmentation, and chyluria. Prognosis is generally good in early cases, but in chronic cases the disease can leave an individual severely disabled with genital damage.

Diagnosis

History and Symptoms

The most spectacular symptom of lymphatic filariasis is elephantiasis—thickening of the skin and underlying tissues—which was the first disease discovered to be transmitted by insects. Elephantiasis is caused when the parasites lodge in the lymphatic system. Elephantiasis affects mainly the lower extremities, whereas ears, mucus membranes, and amputation stumps are rarely affected; however, it depends on the species of filaria. W. bancrofti can affect the legs, arms, vulva, breasts, while Brugia timori rarely affects the genitals.

Laboratory and Findings

The diagnosis is made by identifying microfilariae on a Giemsa stained thick blood film. Blood must be drawn at night, since the microfilaria circulate at night, when their vector, the mosquito, is most likely to bite. There are also PCR assays available for making the diagnosis.

Treatment

Medical Therapy

The recommended treatment for patients outside the United States is albendazole (a broad spectrum anthelmintic) combined with ivermectin.[4] A combination of diethylcarbamazine (DEC) and albendazole is also effective. All of these treatments are microfilaricides; they have no effect on the adult worms.

Primary prevention

There are many primary preventive measures available for filariasis. Wearing appropriate clothing, Avoid outbreaks, Insecticides and Spatial Repellents,Bed nets and Mass drug treatment programs are efficient ways to prevent filariasis.

References

  1. 1.0 1.1 1.2 Chandy A, Thakur AS, Singh MP, Manigauha A (2011). "A review of neglected tropical diseases: filariasis". Asian Pac J Trop Med. 4 (7): 581–6. doi:10.1016/S1995-7645(11)60150-8. PMID 21803313.
  2. CDC https://www.cdc.gov/parasites/lymphaticfilariasis/epi.html Accessed on June 26, 2017
  3. Aupali T, Ismid IS, Wibowo H; et al. (2006). "Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper". Tran R Soc Trop Med Hyg. 100 (8): 753&ndash, 9.
  4. U.S. Centers for Disease Control, Lymphatic Filariasis Treatment, retrieved 2008-07-17


Template:WikiDoc Sources